From: Biobanking across the phenome - at the center of chronic disease research
Locus, gene | dbSNP ID | NCD entity associated with SNP | P-value | Risk allele frequency | PubMed ID |
---|---|---|---|---|---|
Cancer linked NCDs cluster | |||||
5p15.33, TERT | rs2736100 | Glioma | 2.00E-17 | 0.49 | 19578367 |
 | rs2736100 | Glioma | 1.00E-14 | NR | 21531791 |
 | rs2736100 | Glioma | 7.00E-09 | NR | 21827660 |
 | rs2736100 | Hematological and biochemical traits | 3.00E-08 | 0.4 | 20139978 |
 | rs2736100 | Idiopathic pulmonary fibrosis | 3.00E-08 | 0.41 | 18835860 |
 | rs2736100 | Lung adenocarcinoma | 2.00E-22 | 0.39 | 20700438 |
 | rs2736100 | Lung adenocarcinoma | 3.00E-11 | 0.39 | 20871597 |
 | rs2736100 | Lung cancer | 1.00E-27 | 0.41 | 21725308 |
 | rs2736100 | Testicular germ cell cancer | 8.00E-15 | 0.49 | 20543847 |
5p15.33, TERT, CLPTM1L | rs401681 | Bladder cancer | 5.00E-07 | 0.54 | 20972438 |
 | rs401681 | Lung cancer | 8.00E-09 | NR | 18978787 |
 | rs401681 | Melanoma | 3.00E-08 | 0.46 | 21983787 |
 | rs401681 | Pancreatic cancer | 7.00E-07 | 0.45 | 20101243 |
 | rs401681 | Serum prostate-specific antigen levels | 1.00E-10 | 0.55 | 21160077 |
8q24.21, Intergenic | rs6983267 | Colorectal cancer | 1.00E-14 | 0.49 | 17618284 |
 | rs6983267 | Colorectal cancer | 7.00E-11 | 0.48 | 18372905 |
 | rs6983267 | Colorectal cancer | 2.00E-08 | 0.34 | 21242260 |
 | rs6983267 | Prostate cancer | 9.00E-13 | 0.5 | 17401363 |
 | rs6983267 | Prostate cancer | 9.00E-13 | 0.49 | 18264097 |
 | rs6983267 | Prostate cancer | 7.00E-12 | 0.53 | 18264096 |
 | rs6983267 | Prostate cancer | 9.00E-06 | NR | 21743057 |
9p21.3, CDKN2A, CDKN2B | rs4977756 | Glaucoma | 1.00E-14 | 0.6 | 21532571 |
 | rs4977756 | Glioma | 7.00E-15 | 0.6 | 19578367 |
Inflammatory trait linked NCDs cluster | |||||
1p31.3, IL23R | rs11209026 | Ankylosing spondylitis | 2.00E-17 | 0.93 | 21743469 |
 | rs11209026 | Ankylosing spondylitis | 9.00E-14 | 0.94 | 20062062 |
 | rs11209026 | Crohn’s disease | 1.00E-64 | 0.93 | 21102463 |
 | rs11209026 | Crohn’s disease | 4.00E-21 | NR | 22293688 |
 | rs11209026 | Crohn’s disease | 2.00E-18 | 0.92 | 17447842 |
 | rs11209026 | Inflammatory bowel disease | 4.00E-11 | 0.93 | 17068223 |
 | rs11209026 | Inflammatory bowel disease | 7.00E-11 | 0.94 | 18758464 |
 | rs11209026 | Psoriasis | 7.00E-07 | NR | 20953190 |
 | rs11209026 | Ulcerative colitis | 5.00E-28 | 0.94 | 21297633 |
 | rs11209026 | Ulcerative colitis | 3.00E-10 | NR | 19915572 |
 | rs11209026 | Ulcerative colitis | 1.00E-08 | 0.93 | 19122664 |
1p13.2, PTPN22 | rs2476601 | Crohn’s disease | 1.00E-08 | 0.9 | 18587394 |
 | rs2476601 | Rheumatoid arthritis | 9.00E-74 | 0.1 | 20453842 |
 | rs2476601 | Rheumatoid arthritis | 2.00E-21 | NR | 19503088 |
 | rs2476601 | Rheumatoid arthritis | 2.00E-11 | 0.1 | 17804836 |
 | rs2476601 | Type 1 diabetes | 9.00E-85 | NR | 19430480 |
 | rs2476601 | Type 1 diabetes | 2.00E-80 | 0.09 | 17554260 |
 | rs2476601 | Type 1 diabetes | 1.00E-07 | 0.09 | 17632545 |
 | rs2476601 | Type 1 diabetes autoantibodies | 2.00E-111 | NR | 21829393 |
 | rs2476601 | Vitiligo | 1.00E-07 | 0.1 | 20410501 |
7q32.1, IRF5,TNPO3 | rs10488631 | Primary biliary cirrhosis | 3.00E-10 | 0.11 | 20639880 |
 | rs10488631 | Primary biliary cirrhosis | 2.00E-07 | NR | 19458352 |
 | rs10488631 | Rheumatoid arthritis | 4.00E-11 | 0.11 | 20453842 |
 | rs10488631 | Systemic lupus erythematosus | 7.00E-18 | 0.11 | 21408207 |
 | rs10488631 | Systemic lupus erythematosus | 2.00E-11 | 0.12 | 18204098 |
 | rs10488631 | Systemic sclerosis | 2.00E-13 | NR | 20383147 |
 | rs10488631 | Systemic sclerosis | 2.00E-10 | NR | 21779181 |
 | rs10488631 | Systemic sclerosis | 2.00E-07 | NR | 21779181 |
 | rs10488631 | Systemic sclerosis | 4.00E-07 | 0.09 | 21750679 |
18p11.21, PTPN2 | rs2542151 | Crohn’s disease | 5.00E-17 | 0.15 | 18587394 |
 | rs2542151 | Crohn’s disease | 3.00E-08 | 0.18 | 17554261 |
 | rs2542151 | Crohn’s disease | 2.00E-07 | 0.16 | 17554300 |
 | rs2542151 | Type 1 diabetes | 1.00E-14 | 0.16 | 17554260 |
 | rs2542151 | Type 1 diabetes | 9.00E-08 | NR | 18978792 |
 | rs2542151 | Type 1 diabetes autoantibodies | 4.00E-13 | NR | 21829393 |
18p11.21, PTPN2 | rs1893217 | Celiac disease | 3.00E-10 | 0.17 | 20190752 |
 | rs1893217 | Celiac disease and Rheumatoid arthritis | 5.00E-12 | NR | 21383967 |
 | rs1893217 | Type 1 diabetes | 4.00E-15 | NR | 19430480 |
Cardiovascular trait linked NCDs cluster | |||||
2p23.3, GCKR | rs1260326 | Cardiovascular disease risk factors | 2.00E-08 | 0.4 | 21943158 |
 | rs1260326 | Cholesterol, total | 7.00E-27 | 0.41 | 20686565 |
 | rs1260326 | Chronic kidney disease | 3.00E-14 | 0.41 | 20383146 |
 | rs1260326 | C-reactive protein | 5.00E-40 | NR | 21300955 |
 | rs1260326 | Hematological and biochemical traits | 4.00E-09 | 0.44 | 20139978 |
 | rs1260326 | Hypertriglyceridemia | 7.00E-09 | 0.41 | 20657596 |
 | rs1260326 | Liver enzyme levels (gamma-glutamyl transferase) | 4.00E-13 | 0.38 | 22001757 |
 | rs1260326 | Metabolic traits | 4.00E-10 | 0.35 | 19060910 |
 | rs1260326 | Platelet counts | 9.00E-10 | NR | 22139419 |
 | rs1260326 | Serum metabolites | 3.00E-18 | NR | 22286219 |
 | rs1260326 | Triglycerides | 6.00E-133 | 0.41 | 20686565 |
 | rs1260326 | Triglycerides | 2.00E-31 | 0.45 | 19060906 |
 | rs1260326 | Two-hour glucose challenge | 3.00E-10 | NR | 20081857 |
 | rs1260326 | Waist circumference and related phenotypes | 4.00E-08 | NR | 18454146 |
11q12.2, FADS1, FADS2 | rs174547 | HDL cholesterol | 2.00E-12 | 0.33 | 19060906 |
 | rs174547 | Lipid metabolism phenotypes | 8.00E-262 | NR | 22286219 |
 | rs174547 | Metabolic traits | 9.00E-116 | 0.32 | 21886157 |
 | rs174547 | Phospholipid levels (plasma) | 4.00E-154 | NR | 21829377 |
 | rs174547 | Phospholipid levels (plasma) | 3.00E-64 | NR | 21829377 |
 | rs174547 | Resting heart rate | 2.00E-09 | 0.33 | 20639392 |
 | rs174547 | Serum metabolites | 7.00E-179 | 0.3 | 20037589 |
 | rs174547 | Triglycerides | 2.00E-14 | 0.33 | 19060906 |
11q14.3, MTNR1B | rs1387153 | Fasting plasma glucose | 2.00E-36 | 0.29 | 19060909 |
 | rs1387153 | Glycated hemoglobin levels | 4.00E-11 | 0.28 | 20858683 |
 | rs1387153 | Metabolic syndrome (bivariate traits) | 2.00E-09 | NR | 21386085 |
 | rs1387153 | Metabolic syndrome (bivariate traits) | 8.00E-09 | NR | 21386085 |
 | rs1387153 | Type 2 diabetes | 8.00E-15 | NR | 20581827 |
12q24.12, ALDH2, BRAP | rs671 | Coronary heart disease | 2.00E-34 | 0.23 | 21971053 |
 | rs671 | Drinking behavior | 4.00E-211 | 0.75 | 21372407 |
 | rs671 | Esophageal cancer | 3.00E-24 | NR | 19698717 |
 | rs671 | Hematological and biochemical traits | 7.00E-10 | 0.26 | 20139978 |
 | rs671 | Hematological and biochemical traits | 5.00E-09 | 0.26 | 20139978 |
 | rs671 | Intracranial aneurysm | 3.00E-06 | 0.75 | 22286173 |
 | rs671 | Triglycerides | 2.00E-06 | NR | 22171074 |
16q13, CETP | rs3764261 | Age-related macular degeneration | 7.00E-09 | 0.33 | 21665990 |
 | rs3764261 | Age-related macular degeneration | 7.00E-07 | 0.32 | 20385819 |
 | rs3764261 | Cholesterol, total | 7.00E-14 | 0.32 | 20686565 |
 | rs3764261 | HDL cholesterol | 2.00E-57 | 0.31 | 18193043 |
 | rs3764261 | HDL cholesterol | 7.00E-29 | 0.28 | 19060910 |
 | rs3764261 | HDL cholesterol | 3.00E-12 | 0.2 | 19359809 |
 | rs3764261 | HDL cholesterol | 7E-380 | 0.32 | 20686565 |
 | rs3764261 | LDL cholesterol | 9.00E-13 | 0.32 | 20686565 |
 | rs3764261 | Lipid metabolism phenotypes | 1.00E-36 | NR | 22286219 |
 | rs3764261 | Metabolic syndrome | 1.00E-48 | 0.36 | 20694148 |
 | rs3764261 | Metabolic syndrome | 3.00E-13 | NR | 21386085 |
 | rs3764261 | Triglycerides | 1.00E-12 | 0.45 | 20686565 |
 | rs3764261 | Waist circumference | 1.00E-27 | NR | 18454146 |
19p13.2, LDLR | rs6511720 | Cardiovascular disease risk factors | 5.00E-11 | 0.11 | 21943158 |
 | rs6511720 | Carotid intima media thickness | 1.00E-07 | NR | 21909108 |
 | rs6511720 | Cholesterol, total | 7.00E-97 | 0.11 | 20686565 |
 | rs6511720 | LDL cholesterol | 4.00E-117 | 0.11 | 20686565 |
 | rs6511720 | LDL cholesterol | 2.00E-51 | 0.1 | 18193044 |
 | rs6511720 | LDL cholesterol | 2.00E-26 | 0.1 | 19060906 |
 | rs6511720 | LDL cholesterol | 4.00E-26 | 0.9 | 18193043 |
 | rs6511720 | Lp-PLA2 activity and mass | 3.00E-11 | 0.1 | 22003152 |
19q13.32, APOE, APOC1 | rs4420638 | Alzheimer’s disease | 2.00E-44 | NR | 17998437 |
 | rs4420638 | Alzheimer’s disease | 1.00E-39 | NR | 17975299 |
 | rs4420638 | Alzheimer’s disease (age of onset) | 1.00E-12 | NR | 22005931 |
 | rs4420638 | Alzheimer’s disease (late onset) | 1.00E-39 | NR | 17474819 |
 | rs4420638 | Cholesterol, total | 5.00E-111 | 0.17 | 20686565 |
 | rs4420638 | Cognitive decline | 4.00E-27 | NR | 22054870 |
 | rs4420638 | C-reactive protein | 9.00E-139 | NR | 21300955 |
 | rs4420638 | C-reactive protein | 5.00E-27 | NR | 19567438 |
 | rs4420638 | C-reactive protein | 3.00E-07 | 0.9 | 21196492 |
 | rs4420638 | HDL cholesterol | 4.00E-21 | 0.17 | 20686565 |
 | rs4420638 | LDL cholesterol | 9.00E-147 | 0.17 | 20686565 |
 | rs4420638 | LDL cholesterol | 1.00E-60 | 0.2 | 18193044 |
 | rs4420638 | LDL cholesterol | 3.00E-43 | 0.18 | 18193043 |
 | rs4420638 | LDL cholesterol | 2.00E-40 | 0.18 | 20864672 |
 | rs4420638 | LDL cholesterol | 4.00E-27 | 0.16 | 19060906 |
 | rs4420638 | LDL cholesterol | 1.00E-20 | 0.18 | 18262040 |
 | rs4420638 | LDL cholesterol | 2.00E-07 | NR | 18802019 |
 | rs4420638 | Lp-PLA2 activity and mass | 5.00E-30 | 0.84 | 22003152 |
 | rs4420638 | Lp-PLA2 activity and mass | 6.00E-24 | 0.16 | 20442857 |
 | rs4420638 | Longevity | 2.00E-16 | 0.81 | 21740922 |
 | rs4420638 | Quantitative traits | 3.00E-07 | 0.21 | 19197348 |
 | rs4420638 | Triglycerides | 3.00E-13 | 0.22 | 17463246 |
Cardiovascular & inflammatory trait linked NCDs cluster | |||||
12q24.12, SH2B3 | rs3184504 | Coronary heart disease | 6.00E-06 | 0.44 | 21378990 |
 | rs3184504 | Diastolic blood pressure | 4.00E-25 | 0.47 | 21909115 |
 | rs3184504 | Diastolic blood pressure | 3.00E-14 | 0.48 | 19430479 |
 | rs3184504 | Eosinophil counts | 7.00E-19 | 0.38 | 19198610 |
 | rs3184504 | Rheumatoid arthritis | 6.00E-06 | 0.51 | 20453842 |
 | rs3184504 | Systolic blood pressure | 5.00E-09 | 0.48 | 19430479 |
 | rs3184504 | Type 1 diabetes | 3.00E-27 | NR | 19430480 |
 | rs3184504 | Type 1 diabetes autoantibodies | 2.00E-38 | NR | 21829393 |
12q24.12, SH2B3, ATXN2 | rs653178 | Blood pressure | 7.00E-20 | 0.59 | 21909110 |
 | rs653178 | Celiac disease | 7.00E-21 | 0.5 | 20190752 |
 | rs653178 | Celiac disease | 8.00E-08 | 0.48 | 18311140 |
 | rs653178 | Celiac disease and Rheumatoid arthritis | 3.00E-19 | NR | 21383967 |
 | rs653178 | Chronic kidney disease | 4.00E-11 | 0.5 | 20383146 |
 | rs653178 | Diastolic blood pressure | 3.00E-18 | 0.53 | 19430483 |
Skin pigmentation linked NCDs cluster | |||||
11q14.3, TYR | rs1393350 | Blue vs. green eyes | 3.00E-12 | 0.23 | 17952075 |
 | rs1393350 | Eye color | 3.00E-09 | 0.27 | 20585627 |
 | rs1393350 | Melanoma | 2.00E-14 | 0.27 | 19578364 |
 | rs1393350 | Melanoma | 2.00E-13 | 0.28 | 21983787 |
 | rs1393350 | Skin sensitivity to sun | 2.00E-06 | 0.27 | 17952075 |
 | rs1393350 | Tanning | 2.00E-13 | NR | 19340012 |
 | rs1393350 | Vitiligo | 2.00E-18 | 0.73 | 20410501 |
16q24.3, MC1R | rs1805007 | Basal cell carcinoma | 4.00E-17 | 0.07 | 21700618 |
 | rs1805007 | Blond vs. brown hair color | 2.00E-13 | 0.08 | 17952075 |
 | rs1805007 | Freckles | 1.00E-96 | 0.05 | 17952075 |
 | rs1805007 | Red vs non-red hair color | 2.00E-142 | NR | 17952075 |
 | rs1805007 | Skin sensitivity to sun | 2.00E-55 | 0.06 | 17952075 |